Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business

    LAVAL, QC, Jan. 30 /CNW Telbec/ - Neurochem Inc. (NASDAQ:   NRMX; TSX: NRM)
is pleased to announce that Mr. Gary Schmid will join Neurochem, effective
February 4, 2008, and will serve as Chief Executive Officer (CEO) of the new
business Neurochem has announced it is creating to develop and market
nutraceuticals. Mr. Schmid joins the Company from Santé Naturelle A.G.
Limited, the international manufacturers and marketers of Quebec's
market-leading Adrien Gagnon natural health brands. Mr. Schmid joined Santé
Naturelle in May 2006 as Chief Operating Officer and was appointed President
and CEO later that year. In addition, Mr. Schmid spent 20 years at Abbott
Laboratories Ltd. in a variety of positions of ever-increasing responsibility
in sales and marketing where, in 2005, he was appointed General Manager,
Abbott Nutrition.
    "We are excited to welcome Mr. Schmid who will lead the team responsible
for the commercialization of our first nutraceutical product, homotaurine,
developed to enhance memory and cognition. The launch of homotaurine is
planned in Canada in the near future, with subsequent commercial activities in
other territories expected soon thereafter," said Dr. Francesco Bellini,
Chairman, President and Chief Executive Officer of Neurochem. "Mr. Schmid's
long track record and world-class marketing credentials will help create a
unique, branded nutraceutical product company," he concluded.
    As President and CEO of Santé Naturelle A.G., Mr. Schmid succeeded in
developing and implementing that company's strategies to support future growth
expectations, which translated into significantly increasing sales in domestic
and export business segments and in the launch of 35 new products within
12 months.
    Before joining Santé Naturelle, Mr. Schmid held positions with Abbott
Laboratories Ltd. (Canada), where he served between 1985 and 2006, initially
as a financial analyst with what was to become Abbott's nutrition division,
and then rapidly moved into sales and marketing. Following a two-year
assignment with Abbott International Ltd. in Chicago, Mr. Schmid returned to
Canada in 1994 as National Sales Manager of the future nutrition division,
progressed to a series of more responsible positions in marketing, including
Marketing Director of Abbott's Pharma Division, before being appointed General
Manager, Abbott Nutrition, in 2005. Mr. Schmid is a Commerce graduate of
McGill University.

    About Neurochem

    Neurochem Inc. is a global health company focused on the research,
development and commercialization of products to provide innovative health
solutions to patients suffering from serious diseases.

    To Contact Neurochem

    For additional information on Neurochem and its drug development
programs, please call the North American toll-free number 1-877-680-4500 or
visit our Web Site at

    Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Neurochem Inc.'s
control. Such risks include but are not limited to: the impact of general
economic conditions, general conditions in the pharmaceutical and/or
nutraceutical industry, changes in the regulatory environment in the
jurisdictions in which the Neurochem group does business, stock market
volatility, fluctuations in costs, and changes to the competitive environment
due to consolidation, that actual results may vary once the final and
quality-controlled verification of data and analyses has been completed, as
well as other risks disclosed in public filings of Neurochem Inc.
Consequently, actual future results may differ materially from the anticipated
results expressed in the forward-looking statements. The reader should not
place undue reliance, if any, on any forward-looking statements included in
this news release. These statements speak only as of the date made and
Neurochem Inc. is under no obligation and disavows any intention to update or
revise such statements as a result of any event, circumstances or otherwise.
Please see the Annual Information Form of Neurochem Inc. for further risk
factors that might affect the Neurochem group and its business.

For further information:

For further information: Lise Hébert, PhD, Vice President, Corporate
Communications, (450) 680-4572,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890